Impacts of competition and phenotypic plasticity on the viability of adaptive therapy.

Abstract excerpt

Cancer is heterogeneous and variability in drug sensitivity is widely documented across cancer types. Adaptive therapy is an emerging treatment strategy that leverages this heterogeneity to improve therapeutic outcomes. Current standard treatments eliminate a majority of drug-sensitive cells, leading to relapse by competitive release. Adaptive therapy retains some drug-sensitive cells, limiting resistant cell...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Resistance, Neoplasm
• Share to Models, Biological